![Global measles threat: deaths increase by almost 50% in 2022](https://en.sbmt.org.br/wp-content/uploads/2024/01/Sarampo.jpeg)
Newsletter 141 – Dengue: Takeda’s vaccine is approved in Brazil
The granting of the registration by Anvisa allows the commercialization of the product in the country, as long as the approved conditions are maintained
14/04/2023The granting of the registration by Anvisa allows the commercialization of the product in the country, as long as the approved conditions are maintained